0

AN INTERVIEW WITH SHARON BROWNE-PETER, A SICKLE CELL DIVA

Let’s start with a brief introduction. Tell us about you? Sharon: My name is Sharon Browne-Peter. I’m 23 with a bachelor’s degree in Real Estate and Urban Planning. In addition to this, I’ve spent the last 2 years working as a certified digital marketing professional. This year I actually founded my...

0

FIRST AFRICAN CONGRESS ON SCD

In October 2019, key stakeholders including medical & sickle cell experts, governmental and non-governmental organizations from across Africa and the World came together as a collective on one international stage to discuss the burden of sickle cell disease, its impact on African communities and proffer evidence-based solutions and recommendations to...

0

A PASSIONATE APPEAL

AJIRIOGHENE OROMENA OGBOI (NEE UZIEWE) is a 35-year-old sickle cell patient and suffers from necrosis in her hips, leaving her bedridden and necessitating URGENT hip replacement surgery. She needs N3.8 million for the surgery. Since May 2019 when the condition developed, this mother of an eight-year-old boy has been in...

0

MYTHS ABOUT SEX BY DR BECKY SOLOMON

This is going to be an interactive section. Pls I need everyone to think about the things they heard about sex. I would answer if it is true or false. SEXUAL HEALTH  So Human Sexuality is an integral part of our existence, it is a vital aspect of humanity and...

DEPRESSION AND STRESS IN WARRIORS BY DR BECKY 1

DEPRESSION AND STRESS IN WARRIORS BY DR BECKY

So I’m sure you’re wondering why I am talking about this topic. It is very dear to my heart, because we as warriors live with a chronic disease which predisposes us to A Lot of Stress and Even Clinical Depression.  We need to learn How to Manage either aspects or...

1

FDA approves Oxbryta for SCD

The FDA granted accelerated approval to voxelotor for the treatment of sickle cell disease. The approval applies to use of the therapy for patients aged 12 years and older. Voxelotor (Oxbryta, Global Blood Therapeutics) — an oral agent taken once daily — is the first approved treatment that directly inhibits...